Honors

Lee Denson, MD, 
Director, Schubert-Martin IBD Center, received a $100,000 Sherman Prize from the Bruce and Cynthia Sherman Charitable Foundation in recognition of his career of achievements in improving the health and wellness of people living with Crohn’s disease and ulcerative colitis.

Todd Florin, MD, MSCE,
Emergency Medicine, was elected to represent Emergency Medicine on the Society for Pediatric Research Council.

Maryam Fouladi, MD, MSc,
Oncology, was selected to participate in the Executive Leadership in Academic Medicine (ELAM) program.

Victor Garcia, MD,
Founding Director, Trauma Services, was recently named a Great Living Cincinnatian by the Cincinnati USA Regional Chamber.

Mike Gittelman, MD,

Emergency Medicine, was named President-Elect for the Ohio Chapter of the American Academy of Pediatrics.

Haleh Heydarian, MD, 
Cardiology, was inducted as a Fellow of the American College of Cardiology. 

James McCarthy, MD, MHCM,
Director, Pediatric Orthopaedics, was elected President of the Pediatric Orthopaedic Society of North America.

Mary McMahon, MD, 
Director, Division of Physical Medicine and Rehabilitation, was elected Secretary of the American Board of Physical Medicine and Rehabilitation.

Halima Moncrieffe, PhD, 
Center for Autoimmune Genomics and Etiology (CAGE), was named a TEDMED Research Scholar and was selected as part of a Black Science Network feature for Black History Month.

Jennifer O’Toole, MD, MEd,
Hospital Medicine, received the inaugural Brendan Kelly Award from the Medicine-Pediatrics Program Directors Association.

Joe Real, MD, 
General and Community Pediatrics, recently received the APA Young Investigator Award, the Ray Helfer Presentation Award, and the Children’s Journal Travel Award.

Paul Spearman, MD, 
Director, Infectious Diseases, was elected President (2017-18) of the Pediatric Infectious Diseases Society.

Sandy Staveski, PhD, RN, APRN, 
Heart Institute, was elected President of the Pediatric Cardiac Intensive Care Society. 

Sarat Thikkurissy, DDS, MS,
Dentistry, was named Pediatric Dentist of the Year by the American Academy of Pediatric Dentistry.

Jilda Vargus-Adams, MD, MSc,
Physical Medicine and Rehabilitation, was elected President (2018) of the American Academy of Cerebral Palsy.

Muglia to Direct Human Genetics

Louis Muglia

Louis Muglia, MD, PhD

Louis Muglia, MD, PhD, has been appointed to the role of A. Graeme Mitchell chair and Director of the Division of Human Genetics.

Muglia, who trained in pediatrics and pediatric endocrinology at Boston Children’s, came to the Perinatal Institute at Cincinnati Children’s in January 2012 after faculty positions at Washington University in St. Louis (1996-2008) and Vanderbilt University Medical Center (2008-2012), where he also served as vice chair for research.

Muglia’s bibliography includes more than 215 peer-reviewed publications and chapters. His expertise in the genetics of preterm birth has been nationally and internationally recognized with a Lucille Markey Charitable Trust Scholar award, a Burroughs-Wellcome Fund Career Development Award, and multiple NIH R01s since 2001. 

McAuliffe Named Anesthesiologist-in-Chief

John McAuliffe

John McAuliffe III, MD, MBA

John McAuliffe III, MD, MBA, has been appointed anesthesiologist-in-chief at Cincinnati Children’s after  serving as interim chief since last March. 

McAuliffe replaces Dean Kurth, MD, who after 13 years at Cincinnati Children’s returned to Children’s Hospital of Philadelphia. 

McAuliffe began his career at Cincinnati Children’s in 1985 in the Department of Anesthesia. By 1994, he was named associate director. From 2002-2014, he served as research director. Beginning in 2008 until last year, he added the role of director of the Division of Neurobiology. Since 2010, he has been section chief of Intraoperative Neurophysiological Monitoring. 

 

Grants

From Feb. 1 to June 30, researchers at Cincinnati Children’s were awarded 214 grants valued at $105.8 million in total costs. Here are the recipients of grants exceeding $1 million:

David I. Bernstein, MD, MA,
Infectious Diseases, received a three-year, $1.3 million grant from the National Institute of Allergy and Infectious Diseases, to study the implementation of the Vaccine and Treatment Evaluation Units, a national group of institutions that conducts clinical trials of promising candidate vaccines and therapies for a variety of infectious diseases. 

Samantha A. Brugmann, PhD, 
Plastic Surgery, will study the role of primary cilia in murine craniofacial development, using a six-year, $2 million grant from the National Institute of Dental and Craniofacial Research.

Robert C. Coghill, PhD,
Director of Research, Anesthesia, received a three-year, $2.8 million grant from the National Institute of Neurological Disorders and Stroke, to study the brain mechanisms that account for individual differences in pain. 

Steve Danzer, PhD, 
Anesthesia, received a five-year, $1.8 million grant from the National Institute of Neurological Disorders and Stroke, to study the identification and reversal of primary and secondary epileptogenic changes in patients with epilepsy. He also received a three-year, $2 million grant from the same agency to study mTOR regulation of aberrant neuronal integration and epilepsy.

Stella Davies, MBBS, PhD,
Director, Bone Marrow Transplant and Immune Deficiency, received a five-year, $1.1 million grant from the National Cancer Institute for her role with the Childhood Cancer Survivor Study. The project examines the late effects of patients who have survived five years or more following a pediatric cancer diagnosis.

Matthew J. Flick, PhD,
Experimental Hematology & Cancer Biology, received a five-year, $2.3 million grant from the National Cancer Institute to study the thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease.

Patricia Fulkerson, MD, PhD,

Allergy and Immunology, will study the role of Aiolos in eosinophilic asthma, using a five-year, $2 million grant from the National Institute of Allergy and Infectious Diseases.

Richard Gilman, PhD, 
Child and Adolescent Psychiatry, received a three-year, $1.2 million grant from the Department of Justice for his work in the Campbell County (Ky.) School District’s efforts to reduce violence. 

John Harley, MD, PhD,
Director of the Center for Autoimmune Genomics and Etiology (CAGE), will study gene regulation as a foundation for autoimmune disease prevention, using a five-year, $2.7 million grant from the National Institute of Allergy and Infectious Diseases.

Rashmi Hegde, PhD,
Developmental Biology, received a five-year, $1.9 million grant from the National Cancer Institute, to study the linked regulation of tumor angiogenesis.

Michael Helmrath, MD, MS,
General and Thoracic Surgery, received a five-year, $1.9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases, to investigate the regional identity in human intestinal stem cells.

Kevin Hommel, PhD,
Behavioral Medicine and Clinical Psychology, received a five-year, $1.3 million grant from the National Institute of Child Health and Human Development, for his work in enhancing patient adherence to treatment and health outcomes.

Vivian Hwa, PhD,

Endocrinology, will study the roles of STAT5b in IGF-1 production and human growth, with a two-year, $1.6 million grant from the National Institute of Child Health and Human Development.  

Edith Janssen, PhD,
Immunobiology, received a five-year, $1.5 million grant from the National Institute on Aging, to study metabolic alterations in age-associated dendritic cells.

Rulang Jiang, PhD, 
Developmental Biology, will study the molecular regulation of palate development, using a four-year, $1.2 million grant from the Shriners Hospital for Children.

Heather Kaplan, MD, MSCE, 
Neonatology and Pulmonary Biology, received a two-year, $2.6 million grant from the Patient-Centered Outcome Research Institute, to study the use of single subject (N-of-1) designs to answer patient-identified research questions. 

Susmita Kashikar-Zuck, PhD,
Behavioral Medicine and Clinical Psychology, received a five-year, $7.7 million grant from the National Institutes of Arthritis and Musculoskeletal and Skin Diseases, for her role with the multi-site randomized clinical trial of FIT Teens for juvenile fibromyalgia. 

Satish Madala, PhD,
Pulmonary Medicine, will study the WT1 regulation of pulmonary fibrosis, using a five-year, $2 million grant from the National Heart, Lung, & Blood Institute.  

Stephen Meuthing, MD,
Co-Director, James M. Anderson Center for Health Systems Excellence, will study ways to improve the safety of patients, using a one-year, $3 million grant from the Ohio Children’s Hospitals’ Solutions for Patient Safety.

Lou Muglia, MD, PhD,
Co-Director, Perinatal Institute, received a five-year, $3 million grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, to advance the systems-biology approach to discovery of biological pathways in placental development and parturition. He also received a one-year, $2 million grant from the March of Dimes for his work with its Prematurity Research Center Ohio Collaborative. 

Satoshi Namekawa, PhD,
Reproductive Sciences, received a four-year, $1.9 million grant from the National Institute of General Medicine Sciences, to study DNA damage response pathways in meiotic sex chromosome I.

Ernest Pedapati, MD,
Child and Adolescent Psychiatry, will study anomalous sensorimotor physiology in Fragile X Syndrome, using a five-year, $1.3 million grant from the National Institute of Mental Health.

Brenda Poindexter, MD, MS,
Perinatal Institute, received a four-year, $1.7 million grant from the National Institute of Child Health and Human Development, for her work with its Cooperative Multicenter Neonatal Research Network.   

Saulius Sumanas, PhD,
Developmental Biology, will study the role of collagen COL22A1 in intracranial aneurysms, using a four-year, $1.9 million grant from the National Heart, Lung, and Blood Institute.

Takuji Suzuki, MD, PhD, 
Pulmonary Biology, will study genome-edited iPS cell-derived macrophages, using a four-year, $1.6 million grant from the National Heart, Lung, and Blood Institute.

Takanori Takebe, MD,
Gastroenterology, Hepatology and Nutrition, received a three-year, $1.3 million grant from Ono Pharmaceutical Co., Ltd., to study the directing of multi-visceral organ budding from induced pluripotent stem cells.

Sing-Sing Way, MD, PhD,
Infectious Diseases, received a five-year, $2 million grant from the National Institute of Allergy and Infectious Diseases, to study the functional immune tolerance to non-inherited maternal antigen.

Matthew Weirauch, PhD,
CAGE, will study how the binding of Epstein Barr Virus EBNA2 unifies multiple sclerosis genetic mechanisms, using a four-year, $1.1 million grant from the National Institute of Neurological Disorders and Stroke.

Jeffrey Whitsett, MD,
Co-Director, Perinatal Institute, received a four-year, $2.2 million grant from the National Heart, Lung, and Blood Institute, to study the role of EMC3/TMEM111 in alveolar epithelial cell function. He also was awarded a one-year, $1.4 million grant from the agency to study lung and cardiovascular development and disease.  

Yutaka Yoshida, PhD, 
Developmental Biology, received a five-year, $1.1 million grant from the National Institute of Neurological Disorders and Stroke, to study a novel approach to restoring motor function.